FDA Approves ONGLYZA for the Treatment of Type 2 Diabetes in the US
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
AstraZeneca PLC Second Quarter & Half Year Results 2009
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Good first six months in 2009 for Boehringer Ingelheim
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
Pfizer in Partnership with Shanghai Institutes for Biological Sciences for Drug Discovery Activities
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Abbott to Acquire Nutrition Businesses, Expanding Presence in India
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29
- Details
- Category: Amgen
![Amgen Amgen](http://www.worldpharmanews.com/images/stories/logo/amgen.gif)
More Pharma News ...
- Q2/2009: Merck Revenues Remain Steady at € 1.9 Billion
- The US Food and Drug Administration (FDA) has approved Tekturna HCT®
- Genzyme Delivers Solid Second-Quarter Financial Results
- Pfizer Reports Second-Quarter 2009 Revenues of $11.0 Billion
- Xeloda in combination with oxaliplatin shown to be effective in early colon cancer
- Nycomed announces FDA filing for Daxas® in COPD
- Novartis delivers strong operational performance in the first half of 2009